CN108497493A - A kind of food and preparation method thereof improving cranial nerve cell function - Google Patents
A kind of food and preparation method thereof improving cranial nerve cell function Download PDFInfo
- Publication number
- CN108497493A CN108497493A CN201810297539.6A CN201810297539A CN108497493A CN 108497493 A CN108497493 A CN 108497493A CN 201810297539 A CN201810297539 A CN 201810297539A CN 108497493 A CN108497493 A CN 108497493A
- Authority
- CN
- China
- Prior art keywords
- parts
- food
- cranial nerve
- nerve cell
- cell function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003792 cranial nerve Anatomy 0.000 title claims abstract description 58
- 235000013305 food Nutrition 0.000 title claims abstract description 55
- 230000003915 cell function Effects 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 19
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 18
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 17
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 16
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 16
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 15
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 14
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 14
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000010355 mannitol Nutrition 0.000 claims description 21
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 17
- 229930195725 Mannitol Natural products 0.000 claims description 17
- 239000000594 mannitol Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 13
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 13
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 108010039918 Polylysine Proteins 0.000 claims description 11
- 229960001855 mannitol Drugs 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229940074410 trehalose Drugs 0.000 claims description 9
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- 235000021552 granulated sugar Nutrition 0.000 claims description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- 240000009120 Phyllanthus emblica Species 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims 2
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims 1
- 235000021028 berry Nutrition 0.000 claims 1
- 229960005337 lysine hydrochloride Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 210000004556 brain Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 16
- 230000006870 function Effects 0.000 abstract description 10
- 210000004958 brain cell Anatomy 0.000 abstract description 7
- 210000005036 nerve Anatomy 0.000 abstract description 5
- 229920000656 polylysine Polymers 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 150000008106 phosphatidylserines Chemical class 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 150000003625 trehaloses Chemical class 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010029260 Neuroblastoma Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000006386 memory function Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 241000219226 Acer truncatum Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- BRPMGWKECPTJGE-RGMNGODLSA-N Cl.C(CC)N[C@@H](CCO)C(=O)O Chemical compound Cl.C(CC)N[C@@H](CCO)C(=O)O BRPMGWKECPTJGE-RGMNGODLSA-N 0.000 description 1
- 101150076104 EAT2 gene Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of food and preparation method thereof improving cranial nerve cell function, the food for improving cranial nerve cell function contains the raw material of following parts by weight：6~30 parts of 50~200 parts of emblic extract, 5~50 parts of phosphatidylserine, 5~50 parts of Sodium Hyaluronate, 1.5~15 parts of gamma aminobutyric acid, 0.3~3 part of calcium pantothenate and ε polylysines hydrochloride.The food for improving cranial nerve cell function has the function of to adjust the conduction of nerve impulse, promote brain memory and repair the effects that being damaged brain cell; the food for improving cranial nerve cell function described simultaneously is prepared as powdery, sheet, graininess and liquid; the crowd of benefiting from has been widened significantly; and preparation process is simple to operation, is conducive to large-scale production.
Description
Technical field
The present invention relates to field of food, and in particular to a kind of food and preparation method thereof improving cranial nerve cell function.
Background technology
Brain is nerve system of human body command centre, is the organ of most accurate complexity, function it is normal whether directly close
It is the height of body operational efficiency.The increase of change and social pressures however as people's eating habit, more and more people
Due to brain nutrition deficiency and immense pressure in neural sub-health state, be mainly shown as phychasthnia, failure of memory,
Notice that force difference, reaction speed slow down.Therefore how research improves cranial nerve cell function and has become important project.
Current for the food of the prevention of cranial nerve cell sub-health state and routine servicing and few, majority have obviously
It is just treated after symptom, generally uses drug or physical therapy.Drug therapy inevitably has side effect to human body, and cannot be long-term
Maintenance；The physiotherapies curative effect unobvious such as movement, and it is slow to take effect.Trend new in recent years is to replace drug with food, allows people
With operational maintenance replace treat.
The patent of Publication No. CN106665887A《A kind of nutriment improving brain neuroblastoma》Middle selection acer truncatum seed
Oil and phosphatidylserine are primary raw material, cranial nerve fiber and cranial nerve cell film are respectively acting on, to repair injured nerve
Fiber is transmitted with the information ensured in cranial nerve cell.But the invention is limited to the unicity of component material, loses component material
The science plyability of material, the science concertedness of component material, the science balance of component material and the food of application, and then lead
It causes not comprehensive to improving brain neuroblastoma cell functional effect.
Invention content
It is of the existing technology in order to solve the problems, such as, the present invention provides it is a kind of improve cranial nerve cell function food and
Preparation method.The raw-food material for improving cranial nerve cell function is conducive to brain nutrition and balances and match science, has and adjusts
The conduction of nerve impulse is saved, brain memory function is promoted and repairs the effects that being damaged brain cell.
The technical scheme is that：A kind of food improving cranial nerve cell function is provided, following parts by weight are contained
Raw material：50~200 parts of emblic extract, 5~50 parts of phosphatidylserine, 5~50 parts of Sodium Hyaluronate, γ-aminobutyric acid
6~30 parts of 1.5~15 parts, 0.3~3 part of calcium pantothenate and epsilon-polylysine hydrochloride.
Further, the emblic extract specification is 30:1, i.e. 1 parts by weight extract is equivalent to 30 parts by weight emblics
Dry fruit selects the emblic extract of highly enriched degree, and superoxide dismutase in the food for improving cranial nerve cell function can be improved
The content of enzyme.
Further, powdery is made in the food for improving cranial nerve cell function, also needs to be added in preparation process as follows
Parts by weight auxiliary material：400~800 parts of 50~100 parts of mannitol and trehalose.
The preparation method that the powdery improves the food of cranial nerve cell function includes the following steps：Emblic is extracted
Object, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate, mannitol, trehalose and epsilon-polylysine hydrochloric acid
Salt improves the food of cranial nerve cell function up to powdery after being sufficiently mixed uniformly.
Further, graininess is made in the food for improving cranial nerve cell function, also needs to be added such as in preparation process
Lower parts by weight auxiliary material：50~100 parts of mannitol, 550~650 parts of white granulated sugar, 30~50 parts of microcrystalline cellulose, maltodextrin 20
~50 parts and 40~125 parts of water.
The preparation method that the graininess improves the food of cranial nerve cell function includes the following steps：
(1) the poly- bad ammonia of emblic extract, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate, ε-is taken
Acid hydrochloride, mannitol, white granulated sugar, microcrystalline cellulose and maltodextrin are uniformly mixed, and obtain mixture a；
(2) being dried after mixture a being pelletized improves the food of cranial nerve cell function to get graininess.
Further, sheet is made in the food for improving cranial nerve cell function, also needs to be added in preparation process as follows
Parts by weight auxiliary material：50~100 parts of mannitol, 30~50 parts of xylitol, 400~800 parts of trehalose, maltodextrin 20~50
Part, 30~50 parts of microcrystalline cellulose, 10~30 parts of magnesium stearate and 40~50 parts of water.
The preparation method that the sheet improves the food of cranial nerve cell function includes the following steps：
(1) the poly- bad ammonia of emblic extract, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate, ε-is taken
Acid hydrochloride, mannitol, xylitol, trehalose and maltodextrin are uniformly mixed, and obtain mixture b；
(2) dry after mixture b being pelletized, it is uniformly mixed with microcrystalline cellulose and magnesium stearate, after tabletting to obtain the final product
Sheet improves the food of cranial nerve cell function.
Further, liquid is made in the food for improving cranial nerve cell function, also needs to be added in preparation process as follows
Parts by weight auxiliary material：400~500 parts of 50~100 parts of mannitol, 400~800 parts of trehalose and water.
The preparation method that the liquid improves the food of cranial nerve cell function includes the following steps：
(1) mannitol, trehalose and part water are heated to 75~85 DEG C, 20~30min of tanning obtains liquid syrup；
(2) stop heating, Sodium Hyaluronate is added when liquid syrup temperature is down to 50~60 DEG C, and stir evenly, obtains mixed
Close liquid c；
(3) it is poly- bad that emblic extract, phosphatidylserine, γ-aminobutyric acid, calcium pantothenate, ε-are added in mixed liquor c
The water of propylhomoserin hydrochloride and remaining weight filters the food for improving cranial nerve cell function up to liquid after stirring evenly.
Primary raw material effect is as follows in the food for improving cranial nerve cell function：
Emblic extract：Rich in superoxide dismutase, internal ultra-oxygen anion free radical can be removed, and with anti-
Oxidation, anti-inflammatory, radioresistance, antifatigue, antitumor and raising immunity of organisms and other effects.
Phosphatidylserine：Its function mainly improves nerve cell function, adjusts the conduction of nerve impulse, promotes brain
Memory function especially has very strong lipophilicity, blood-brain barrier can be run through after absorption and enters brain, and it is flat to play blood vessel of releiving
Sliding myocyte, increases the effect of brain blood supply；Simultaneously to the various functions of brain, the especially stabilization of the memory of brain and mood
Important adjustment effect is played, affects flowing and the permeability of brain cell membrane, and the metabolism and conjunction of a variety of enzymes can be activated
At.
Sodium Hyaluronate：It can ensure good mobility between internal interstitial, ensure that cell moisture is sufficient and cell membrane
Between circulation conduction.
γ-aminobutyric acid：With raising brain cell activity, improves and remember, alleviate nervous, improvement cephalopin metabolism etc.
Function, while brain activation can be promoted, promote sleep, delay brain aging, supplement human body inhibitory neurotransmitter.
Calcium pantothenate：The metabolism that can participate in carbohydrate, fat and protein is that human body and animal maintain normal physiological
The indispensable micro substance of function.The combination of calcium pantothenate and choline has been proved to improving in raising memory and improving intelligence
Aspect is highly effective.It is exactly phosphatidylserine that the choline of the present invention, which supplements source to be, it must be under the action of calcium pantothenate
It can be absorbed by brain cell, while calcium pantothenate also has human body the effect for supplementing calcium original.
Epsilon-polylysine hydrochloride：Degradable in human body is this essential amino acid of L-lysine, can promote human body
Development, enhancing immune function, and have the function of improving central nervous tissue function, while prepared by epsilon-polylysine hydrochloride
Also mainly play preservative and nutritional agents in the process, can extend the shelf life and the longer time preserves nutritional ingredient.
Beneficial effects of the present invention are：
1, being directed to improves cranial nerve cell function, is equipped with Sodium Hyaluronate with holding brain cell membrane elasticity and with carrying
The γ-aminobutyric acid of high cranial nerve cell vigor, the epsilon-polylysine that can enhance maincenter cranial nerve function of organization is cooperateed with this
Hydrochloride；Phosphatidylserine softening, penetrating cranial nerve cell film, which rise, in component adjusts the conduction of cranial nerve pulse, increases brain
The effects that blood supply, and its main component phosphatidyl choline is combined with calcium pantothenate in component, can be absorbed by brain cell, to change
Kind and raising memory；It is rich in superoxide dismutase in emblic extract, interior free yl can be removed comprehensively, keeps thin
Born of the same parents' vigor, meanwhile, Sodium Hyaluronate can also protect superoxide dismutase activity and function with auxiliary material trehalose and mannitol
Effect；Epsilon-polylysine hydrochloride had not only had the function of preservative in formula but also had been brain because of the lysine decomposed
Nerve provides nutrient, and each component scientific matching is mutually promoted, and more preferable can must play physiologic effect.
2, the preparation method of the food of the present invention for improving cranial nerve cell function, by being added not in primary raw material
Congener auxiliary material, not only enhances nutritional supplementation, but the food for improving cranial nerve cell function can be prepared as powdery,
Granular, sheet and body fluid, that expands significantly benefits from crowd, and preparation process is simple to operation, is conducive to large-scale production.
Specific implementation mode
To make the object, technical solutions and advantages of the present invention clearer, technical scheme of the present invention will be carried out below
Detailed description.Obviously, described embodiments are only a part of the embodiments of the present invention, instead of all the embodiments.Base
Embodiment in the present invention, those of ordinary skill in the art are obtained all without making creative work
Other embodiment belongs to the range that the present invention is protected.
Embodiment 1
Preparing powdery improves the food of cranial nerve cell function, and steps are as follows：
By 10kg emblic extracts, 0.625kg phosphatidylserines, 0.625kg Sodium Hyaluronates, 0.375kg γ-ammonia
Base butyric acid, 0.0625kg calcium pantothenates, 5kg mannitols, 80kg trehaloses and 0.6kg epsilon-polylysine hydrochlorides are sufficiently mixed
The even food for improving cranial nerve cell function to get the powdery.
Embodiment 2
Preparing graininess improves the food of cranial nerve cell function, and steps are as follows：
(1) 15kg emblic extracts, 1.5kg phosphatidylserines, 1.5kg Sodium Hyaluronates, 0.25kg gamma-aminos are taken
Butyric acid, 0.03kg calcium pantothenates, 2kg epsilon-polylysines hydrochloride, 10kg mannitols, 60kg white granulated sugars, 5kg maltodextrins and
5kg microcrystalline celluloses are uniformly mixed, and obtain mixture a；
(2) being dried after mixture a being pelletized improves the food of cranial nerve cell function to get the graininess.
Embodiment 3
Preparing sheet improves the food of cranial nerve cell function, and steps are as follows：
(1) take 20kg emblic extracts, 5kg phosphatidylserines, 5kg Sodium Hyaluronates, 1.5kg γ-aminobutyric acids,
0.3kg calcium pantothenates, 3kg epsilon-polylysines hydrochloride, 5kg mannitols, 4kg xylitols, 2kg maltodextrins and 50kg trehaloses
It is uniformly mixed, obtains mixture b；
(2) dry after mixture b being pelletized, with 30kg microcrystalline celluloses and 20kg magnesium stearate homogenious charge compressions
Piece improves the food of cranial nerve cell function to get the sheet.
Embodiment 4
Preparation solution structural reform is apt to the food of cranial nerve cell function, and steps are as follows：
(1) 5kg mannitols, 40kg trehaloses and 16kg water are heated to 80 DEG C, tanning 25min obtains liquid syrup；
(2) stop heating, 0.5kg Sodium Hyaluronates are added when liquid syrup temperature is down to 60 DEG C, and stir evenly, obtain mixed
Close liquid c；
(3) 5kg emblic extracts, 0.5kg phosphatidylserines, 0.15kg gamma-amino fourths are added in mixed liquor c
Acid, 0.03kg calcium pantothenates, 1kg epsilon-polylysines hydrochloride and 34kg water, filtered after stirring evenly improves brain to get the liquid
The food of nerve cell function.
Following typical case is now chosen, to illustrate the effect for improving cranial nerve cell functional food.
Case 1：Liu, female, 35 years old, enterprise's white collar.
Personal considerations and food consumption process：Mrs Liu causes persistent insomnia, dreaminess, attention because operating pressure is big
Power is not concentrated and failure of memory etc., and working efficiency is caused to be decreased obviously.Its daily eat 2 described food, one time 3~4,
Above-mentioned symptom disappears substantially after 30 weeks, and edible 2 weeks are consolidated.
Case 2：Sun, man, 56 years old, worker.
Personal considerations and food consumption process：Happen suddenly cerebral hemorrhage when Mr. Sun 54 years old, also left after treatment have a dull expression on one's face,
The sequelae such as speak with a lisp, be forgetful, being slow in action.It eats 2 food, 12 bottles, every bottle of 10ml, 40 weeks deutostoma daily
Tooth is unclear, the situation that has a dull expression on one's face completely disappears, and other symptoms are also effectively relieved.
Case 3：Zheng, female, 37 years old, enterprise personnel.
Personal considerations and food consumption process：Mrs Zheng causes loss of appetite, spirit because losing relatives by huge stimulation
The symptoms such as weak.It eats 2 food daily, and 5~8g of powdered food, Mrs's Zheng mental status is completely extensive after 25 weeks
Multiple, diet is normal, and look natural.
The above description is merely a specific embodiment, but scope of protection of the present invention is not limited thereto, any
Those familiar with the art in the technical scope disclosed by the present invention, can easily think of the change or the replacement, and should all contain
Lid is within protection scope of the present invention.Therefore, protection scope of the present invention should be based on the protection scope of the described claims.
Claims (10)
1. a kind of food improving cranial nerve cell function, which is characterized in that the raw material containing following parts by weight：Emblic takes object
50~200 parts, 5~50 parts of phosphatidylserine, 5~50 parts of Sodium Hyaluronate, 1.5~15 parts of γ-aminobutyric acid, calcium pantothenate
0.3~3 part and 6~30 parts of epsilon-polylysine hydrochloride.
2. the food according to claim 1 for improving cranial nerve cell function, which is characterized in that the emblic extract
Specification is 30:1.
3. the preparation method of the food as claimed in claim 1 or 2 for improving cranial nerve cell function, which is characterized in that prepared
It also needs that following parts by weight auxiliary material is added in journey：400~800 parts of 50~100 parts of mannitol and trehalose.
4. the preparation method of the food according to claim 3 for improving cranial nerve cell function, which is characterized in that the system
Preparation Method includes the following steps：By emblic extract, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate,
Mannitol, trehalose and epsilon-polylysine hydrochloride improve the food of cranial nerve cell function up to powdery after being sufficiently mixed uniformly
Product.
5. the preparation method of the food as claimed in claim 1 or 2 for improving cranial nerve cell function, which is characterized in that prepared
It also needs that following parts by weight auxiliary material is added in journey：50~100 parts of mannitol, 550~650 parts of white granulated sugar, microcrystalline cellulose 30~
50 parts and 20~50 parts of maltodextrin.
6. the preparation method of the food according to claim 5 for improving cranial nerve cell function, which is characterized in that the system
Preparation Method includes the following steps：
(1) emblic extract, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate, epsilon-polylysine salt are taken
Hydrochlorate, mannitol, white granulated sugar, microcrystalline cellulose and maltodextrin are uniformly mixed, and obtain mixture a；
(2) being dried after mixture a being pelletized improves the food of cranial nerve cell function to get graininess.
7. the preparation method of the food as claimed in claim 1 or 2 for improving cranial nerve cell function, which is characterized in that prepared
It also needs that following parts by weight auxiliary material is added in journey：50~100 parts of mannitol, 30~50 parts of xylitol, 400~800 parts of trehalose,
10~30 parts of 20~50 parts of maltodextrin, 30~50 parts of microcrystalline cellulose and magnesium stearate.
8. the preparation method of the food according to claim 7 for improving cranial nerve cell function, which is characterized in that the system
Preparation Method includes the following steps：
(1) emblic extract, phosphatidylserine, Sodium Hyaluronate, γ-aminobutyric acid, calcium pantothenate, epsilon-polylysine salt are taken
Hydrochlorate, mannitol, xylitol, trehalose and maltodextrin are uniformly mixed, and obtain mixture b；
(2) dry after mixture b being pelletized, it is uniformly mixed with microcrystalline cellulose and magnesium stearate, up to sheet after tabletting
Improve the food of cranial nerve cell function.
9. the preparation method of the food as claimed in claim 1 or 2 for improving cranial nerve cell function, which is characterized in that prepared
It also needs that following parts by weight auxiliary material is added in journey：400~500 parts of 50~100 parts of mannitol, 400~800 parts of trehalose and water.
10. the preparation method of the food according to claim 9 for improving cranial nerve cell function, which is characterized in that described
Preparation method includes the following steps：
(1) mannitol, trehalose and part water are heated to 75~85 DEG C, 20~30min of tanning obtains liquid syrup；
(2) stop heating, Sodium Hyaluronate is added when liquid syrup temperature is down to 50~60 DEG C, and stir evenly, obtains mixed liquor
c；
(3) it is poly- that emblic berry extract dry powder, phosphatidylserine, γ-aminobutyric acid, calcium pantothenate, ε-are added in mixed liquor c
The water of lysine hydrochloride and remaining weight filters the food for improving cranial nerve cell function up to liquid after stirring evenly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810297539.6A CN108497493A (en) | 2018-04-04 | 2018-04-04 | A kind of food and preparation method thereof improving cranial nerve cell function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810297539.6A CN108497493A (en) | 2018-04-04 | 2018-04-04 | A kind of food and preparation method thereof improving cranial nerve cell function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108497493A true CN108497493A (en) | 2018-09-07 |
Family
ID=63380480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810297539.6A Pending CN108497493A (en) | 2018-04-04 | 2018-04-04 | A kind of food and preparation method thereof improving cranial nerve cell function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108497493A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079396A (en) * | 1992-12-20 | 1993-12-15 | 淄博市淄川区第二制药厂 | Intelligence-enhancing pharmaceutical preparation |
| CN101991817A (en) * | 2009-08-18 | 2011-03-30 | 杨玲 | Brain strengthening and nerve calming medicament |
| CN105477030A (en) * | 2015-12-24 | 2016-04-13 | 北京航天空间医学研究中心 | Phosphatidylserine and gamma aminobutyric acid compound preparation special for astronaut |
-
2018
- 2018-04-04 CN CN201810297539.6A patent/CN108497493A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079396A (en) * | 1992-12-20 | 1993-12-15 | 淄博市淄川区第二制药厂 | Intelligence-enhancing pharmaceutical preparation |
| CN101991817A (en) * | 2009-08-18 | 2011-03-30 | 杨玲 | Brain strengthening and nerve calming medicament |
| CN105477030A (en) * | 2015-12-24 | 2016-04-13 | 北京航天空间医学研究中心 | Phosphatidylserine and gamma aminobutyric acid compound preparation special for astronaut |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103404921A (en) | Fruit/vegetable ferment composition and preparation method thereof | |
| CN103609944A (en) | Blood pressure reducing and sleeping promoting health-care food | |
| CN109511742A (en) | A kind of sleeping fermenting plant protein beverage and preparation method thereof | |
| CN107048422B (en) | Nutritional preparation for rehabilitation of stroke patients | |
| CN106360739A (en) | Composition capable of adjusting blood pressure, reducing blood sugar and complementing nutrition | |
| CN102406115A (en) | Natural functional food for preventing cardiovascular and cerebrovascular diseases | |
| CN103977409A (en) | Dietary supplement composition and blood sugar regulating method thereof | |
| CN106509540A (en) | Drink for enhancing immunity and improving athletic ability | |
| CN105876574A (en) | Manufacture method of Cambodia Noni enzymes | |
| CN101979655A (en) | Enzyme method for producing mung bean peptide | |
| CN104286818B (en) | A kind of salad dressing containing Pollen Maydis and preparation method thereof | |
| CN102125196A (en) | Bee product formulation | |
| CN101263861B (en) | Preparation animal protolysate | |
| CN108523001A (en) | A kind of natto powder and its production technology | |
| CN108497493A (en) | A kind of food and preparation method thereof improving cranial nerve cell function | |
| CN102379416A (en) | Preparation of novel natto health food | |
| CN104509748A (en) | Chicken feed additive and preparation method thereof | |
| CN108660174B (en) | Sesame bioactive peptide for resisting fatigue and promoting intestinal probiotic proliferation | |
| CN111493314A (en) | Food material nutrient with bioactive substances and solid beverage | |
| CN102948733B (en) | Production method and formula of special-eating life nutrition liquid | |
| CN110151746A (en) | A kind of preparation method of fructosyl amino acid nutrient solution | |
| CN102342400A (en) | High-calcium xylitol | |
| CN106942675A (en) | A kind of health-care honey | |
| KR102444884B1 (en) | Extract of Brewer's Yeast Containing High Concentration of Vitamin B1 and B2, and Method for Preparing the Extract | |
| CN101264317A (en) | Preparation of orally-administered protolysate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |
|
| RJ01 | Rejection of invention patent application after publication |